Collectively, CTHRC1 plays important roles in NSCLC progression, and the evaluation of CTHRC1 expression could serve as a potential marker for metastasis progression and prognosis in NSCLC patients. This evidence concerns the gene CTHRC1 and non-small cell lung carcinoma.